SpecGx, LLC recalls Oxycodone and Acetaminophen CII Tablets USP
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.
- Products
-
- Oxycodone and Acetaminophen CII Tablets USP
- Company
- SpecGx, LLC
- Where it was sold
-
Nationwide
Nationwide
- Units affected
- 287,988 Bottles.
- About this recall
- Oxycodone and Acetaminophen CII Tablets USP, 10mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster Groves, MO 63119, NDC 0406-0523-01.